Lonza Group Ltd (LZAGY)
62.99
+1.32
(+2.14%)
USD |
OTCM |
Nov 01, 16:00
Lonza Group 1 Year Total Returns (Daily): 80.19% for Nov. 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 01, 2024 | 80.19% |
October 31, 2024 | 78.08% |
October 30, 2024 | 80.69% |
October 29, 2024 | 82.63% |
October 28, 2024 | 85.61% |
October 25, 2024 | 85.27% |
October 24, 2024 | 74.93% |
October 23, 2024 | 71.90% |
October 22, 2024 | 69.45% |
October 21, 2024 | 69.81% |
October 18, 2024 | 68.88% |
October 17, 2024 | 61.88% |
October 16, 2024 | 31.56% |
October 15, 2024 | 34.65% |
October 14, 2024 | 36.52% |
October 11, 2024 | 29.12% |
October 10, 2024 | 28.03% |
October 09, 2024 | 30.75% |
October 08, 2024 | 30.84% |
October 07, 2024 | 30.49% |
October 04, 2024 | 36.04% |
October 03, 2024 | 39.81% |
October 02, 2024 | 37.74% |
October 01, 2024 | 38.21% |
September 30, 2024 | 37.81% |
Date | Value |
---|---|
September 27, 2024 | 40.34% |
September 26, 2024 | 37.17% |
September 25, 2024 | 33.25% |
September 24, 2024 | 36.63% |
September 23, 2024 | 36.18% |
September 20, 2024 | 29.05% |
September 19, 2024 | 34.04% |
September 18, 2024 | 34.45% |
September 17, 2024 | 15.38% |
September 16, 2024 | 18.80% |
September 13, 2024 | 21.60% |
September 12, 2024 | 18.90% |
September 11, 2024 | 19.81% |
September 10, 2024 | 20.78% |
September 09, 2024 | 19.17% |
September 06, 2024 | 15.30% |
September 05, 2024 | 14.50% |
September 04, 2024 | 15.32% |
September 03, 2024 | 14.66% |
August 30, 2024 | 20.01% |
August 29, 2024 | 20.18% |
August 28, 2024 | 23.14% |
August 27, 2024 | 23.13% |
August 26, 2024 | 23.00% |
August 23, 2024 | 21.33% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-44.81%
Minimum
Sep 23 2022
99.52%
Maximum
Nov 12 2020
17.22%
Average
13.99%
Median
1 Year Total Returns (Daily) Benchmarks
AC Immune SA | 1.69% |
CRISPR Therapeutics AG | 16.02% |
Addex Therapeutics Ltd | 62.12% |
NLS Pharmaceutics Ltd | -87.28% |
Molecular Partners AG | 67.67% |